AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W909. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $759,165 | +26.1% | 53,500 | +8.1% | 0.00% | – |
| Q3 2023 | $601,920 | +63.6% | 49,500 | +68.9% | 0.00% | – |
| Q2 2023 | $368,008 | -5.5% | 29,300 | -8.2% | 0.00% | – |
| Q4 2022 | $389,499 | -74.8% | 31,900 | -78.4% | 0.00% | -100.0% |
| Q3 2022 | $1,543,000 | +1.5% | 147,800 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $1,520,000 | – | 141,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 10,216 | $5,077,000 | 0.30% |
| NEXTHERA CAPITAL LP | 100,000 | $497,000 | 0.29% |
| GROUP ONE TRADING, L.P. | 357,400 | $1,776,000 | 0.02% |
| SIMPLEX TRADING, LLC | 1,408 | $68,000 | 0.00% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 500 | $3,000 | 0.00% |